Skip to main content
Premium Trial:

Request an Annual Quote

Carver Center for Genomics Certified to Offer Roche NimbleGen Array Services


Roche NimbleGen has certified the University of Iowa's Roy J. Carver Center for Genomics to offer microarray services on its platform, Roche said last week.

The company certified the CCG for two array applications: comparative genomic hybridization and gene expression.

CCG Director Harsha Doddapaneni in a statement noted that CCG is the "first academic center in the US" to qualify as a Roche NimbleGen certified service provider.

Bernd Fritzsch, chair of the university's department of biology, added that the center is "progressively exploring the opportunities inherent to the recent progress in genomic analysis" and that becoming a certified service center for NimbleGen arrays is "only the logical next step in this direction."

The CCG also offers chromatin immunoprecipitation-on-chip and sequence capture services on the Roche NimbleGen platform, but the company has not yet certified the center to offer those applications. Roche NimbleGen is the sole array platform offered by the center, which also provides next-generation sequencing services on the Roche 454 GS FLX and the Illumina Genome Analyzer II.

Roche NimbleGen's other American service provider is Aliso Viejo, Calif.-based Ambry Genetics. The company also has CSPs in China, Hong Kong, Taiwan, Korea, Brazil, Turkey, the UK, the Netherlands, and Germany.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.